NTT Precision Medicine and DCT Japan Announce Collaboration to Revolutionize Clinical Trial Participant Recruitment
Last week, our Derrick Sasenarine joined an international roundtable connecting China, the US, and Japan to discuss digital clinical trials and AI, hosted by DIA China’s Digital Health Committee. As the only participant from Japan, he shared perspectives grounded in the Japanese market.
The discussion centered on two questions:
A theme that came through across all three regions: the technology itself is rarely the bottleneck anymore. The real work is integration — building it into trial design, incentives, and delivery from the start, rather than adding it on afterward.
At DCT Japan, this is exactly the conversation we have every day as we support decentralized trial execution in Japan. We’re glad to take part in these cross-regional exchanges — the more we share our experience across markets and learn from one another, the faster the whole field moves forward.
In recent years, “drug lag” and “drug loss” have become significant challenges in Japan. One of the contributing factors is the low participation rate of Japanese sites in international joint clinical trials, often due to “slow enrollment of Japanese patients.”
As Japan’s first company specializing in Decentralized Clinical Trials (DCT), DCT Japan provides comprehensive DCT solutions, including a nationwide network of visiting nurses capable of conducting in-home clinical trials, as well as a network of satellite sites—comprising disease-specific, region-specific, and large hospital groups—to support participant recruitment.
As part of the Integrity Healthcare Group, DCT Japan was established in February 2022 as Japan’s first company specializing in Decentralized Clinical Trials. It provides a comprehensive range of DCT-related solutions, centered on visiting nursing services, IT solutions such as online consultation systems, and participant recruitment through the establishment of satellite site networks.
https://dctj.co.jp/en/
DCT Japan Inc.
Public Relations: pr@dctj.co.jp